AbbVie’s $11B Apogee Acquisition Brings an Eczema Drug With an Edge
Apogee Therapeutics brings AbbVie a long-acting antibody prepared for Part 3 testing in atopic dermatitis, additionally known as eczema. This ...
Apogee Therapeutics brings AbbVie a long-acting antibody prepared for Part 3 testing in atopic dermatitis, additionally known as eczema. This ...
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
Eli Lilly already posted preliminary data showing its obesity drug, Zepbound topped Novo Nordisk’s Wegovy on measures of weight loss ...
With the National Institutes of Health facing deep workforce cuts and little information from agency leadership about how those cuts ...
In a year marked by European Parliament elections and setting of the European Union’s priorities for the next five years, ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.